Does SUMATRIPTAN Cause Therapeutic product effect variable? 13 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Therapeutic product effect variable have been filed in association with SUMATRIPTAN (sumatriptan succinate). This represents 0.1% of all adverse event reports for SUMATRIPTAN.
13
Reports of Therapeutic product effect variable with SUMATRIPTAN
0.1%
of all SUMATRIPTAN reports
0
Deaths
5
Hospitalizations
How Dangerous Is Therapeutic product effect variable From SUMATRIPTAN?
Of the 13 reports, 5 (38.5%) required hospitalization.
Is Therapeutic product effect variable Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUMATRIPTAN. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does SUMATRIPTAN Cause?
Drug ineffective (2,941)
Product physical issue (2,349)
Application site erythema (1,875)
Drug dose omission (1,711)
Product quality issue (1,269)
Application site pain (1,217)
Migraine (978)
Headache (914)
Product complaint (718)
Nausea (702)
What Other Drugs Cause Therapeutic product effect variable?
CARBIDOPA\LEVODOPA (316)
LEVODOPA (298)
RIMEGEPANT (177)
GABAPENTIN (166)
CLOZAPINE (157)
DICLOFENAC (153)
OLANZAPINE (150)
FLUOXETINE (149)
ARIPIPRAZOLE (148)
AMISULPRIDE (147)
Which SUMATRIPTAN Alternatives Have Lower Therapeutic product effect variable Risk?
SUMATRIPTAN vs SUMATRIPTAN\SUMATRIPTAN
SUMATRIPTAN vs SUMAVEL DOSEPRO
SUMATRIPTAN vs SUNITINIB
SUMATRIPTAN vs SUNITINIB MALATE
SUMATRIPTAN vs SUTENT